The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?
Jones
Richard D
RD
Endocrine Heart & Pituitary Group, Academic Unit of Endocrinology, Division of Genomic Medicine, The University of Sheffield, Sheffield, S10 2RX, UK. R.D.Jones@sheffield.ac.uk
Pugh
Peter J
PJ
Jones
T Hugh
TH
Channer
Kevin S
KS
D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D006801:Humans; D015221:Potassium Channels / Q000819:agonists* / Q000378:metabolism*; D013739:Testosterone / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects* / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D015221:Potassium Channels; D014665:Vasodilator Agents; D013739:Testosterone; D002118:Calcium